These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)]. Balon R, Kabesh Ia, Papezhova G. Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437 [Abstract] [Full Text] [Related]
5. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA. J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216 [Abstract] [Full Text] [Related]
6. Early hospital experience with fluphenazine decanoate. Small JG, Kellams J. Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058 [Abstract] [Full Text] [Related]
7. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. Chouinard G, Annable L, Campbell W. J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086 [Abstract] [Full Text] [Related]
11. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses. Roose K. Acta Psychiatr Belg; 1982 Aug; 82(2):216-23. PubMed ID: 7180558 [Abstract] [Full Text] [Related]
16. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Chen H, Kennedy WK, Dorfman JH, Fincham JE, Reeves J, Martin BC. Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734 [Abstract] [Full Text] [Related]
18. Pregnancy and atypical antipsychotics. Ruzić K, Dadić-Hero E, Knez R, Medved P, Petrić D. Psychiatr Danub; 2009 Sep; 21(3):368-70. PubMed ID: 19794358 [Abstract] [Full Text] [Related]
19. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients. Fujikawa M, Togo T, Yoshimi A, Fujita J, Nomoto M, Kamijo A, Amagai T, Uchikado H, Katsuse O, Hosojima H, Sakura Y, Furusho R, Suda A, Yamaguchi T, Hori T, Kamada A, Kondo T, Ito M, Odawara T, Hirayasu Y. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):755-60. PubMed ID: 18226436 [Abstract] [Full Text] [Related]